Official Observers

The Management Committee may designate a limited number of Official Observers to the Management Committee from the World Health Organization and other regulatory authorities on the basis of perceived contribution or value to IMDRF. Official Observers do not participate in the decision making process. Official Observers must be approved by the unanimous consent of the Management Committee and, as with Members, need to be fully knowledgeable on IMDRF matters.

• Argentina, National Administration of Drugs, Food and Medical Devices
• World Health Organization (WHO)
• Swissmedic

.

IMDRF Official Observer Representatives

Argentina, National Administration of Drugs, Food and Medical Devices

• Dr. Marcela Rizzo
  Director of the National Institute of Medical Devices (INPM)
  National Administration of Drugs, Food and Medical Devices (ANMAT)
  Email: marcela.rizzo [at] anmat.gob.ar (marcela[dot]rizzo[at]anmat[dot]gob[dot]ar)
• Rodrigo Pineiro
  Director of the Office of the Institutional Relations
  National Administration of Drugs, Food and Medical Devices (ANMAT)
  Email: rodrigo.pineiro [at] anmat.gob.ar (rodrigo[dot]pineiro[at]anmat[dot]gob[dot]ar)

World Health Organization (WHO)

• Mr Hiiti Sillo
  Unit Head, Regulation and Safety
  World Health Organisation (WHO)
  Email: silloh [at] who.int (silloh[at]who[dot]int)
• Ms Irena Prat
  Team Lead, In Vitro Diagnostic Assessment
  World Health Organisation (WHO)
  Email: prati [at] who.int (prati[at]who[dot]int)

Swissmedic

• Mr Markus Wälti
  Head of Division
  Division Medical Devices Vigilance
  Swiss Agency for Therapeutic Products
  Email: Markus.waelti [at] swissmedic.ch (Markus[dot]waelti[at]swissmedic[dot]ch)
• Mr Andre Breisinger
  Market Surveillance
  Expert Medical Devices Regulation
  Swiss Agency for Therapeutic Products
  Email: andre.breisinger [at] swissmedic.ch (andre[dot]breisinger[at]swissmedic[dot]ch)